RxDoctor Payments Data

Timothy Goetze

Family Medicine · Beaver Falls, PANPI 1497979272

Payments from drug & device makers

$1,471in general payments, 2019–2025

Across 111 payments — averaging $13.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$187
  • Johnson & Johnson$186
  • Sanofi-aventis U.S. LLC$175
  • Novo Nordisk$173
  • Lilly USA, LLC$152
  • Pfizer$131
  • plus $466 from 13 others

What the payments were for

  • Food & beverage$1,45299%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,471 in reported general payments places this provider in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide208$223,810
FarxigaDapagliflozin Propanediol195$223,592
TrulicityDulaglutide204$215,094
JardianceEmpagliflozin199$205,183
MounjaroTirzepatide89$104,313
TradjentaLinagliptin92$79,851
Trelegy ElliptaFluticasone/Umeclidin/Vilanter65$55,812
XareltoRivaroxaban55$49,276
Spiriva RespimatTiotropium Bromide72$40,317
Advair HfaFluticasone Propion/Salmeterol71$34,407
EliquisApixaban40$34,172
InvokanaCanagliflozin33$29,158
Stiolto RespimatTiotropium Br/Olodaterol Hcl51$28,286
Breo ElliptaFluticasone/Vilanterol60$25,298
JanuviaSitagliptin Phosphate13$21,341

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat, Stiolto Respimat, Jentadueto$65$370,824436 claims
Lilly USA, LLCTrulicity, Mounjaro$152$319,407293 claims
AstraZenecaFarxiga, Symbicort$12$235,576236 claims
Novo NordiskOzempic$173$223,810208 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$187$96,190150 claims
Johnson & JohnsonXarelto, Invokana$186$78,43488 claims
MerckJanuvia, Janumet, Dulera$31$49,75867 claims
PfizerEliquis$131$34,17240 claims
NovartisEntresto$19$19,63814 claims
AbbVieLinzess$57$12,17413 claims
Sanofi-aventis U.S. LLCAmbien$175$6,92312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Beaver Falls

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →